Ishihara Sangyo Kaisha (4028) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
20 Nov, 2025Executive summary
Net sales for Q3 FY2025 rose 7.0% year-over-year to ¥105,422 million, with operating income up 54.4% to ¥3,834 million and ordinary income up 6.6% to ¥5,631 million.
Net income declined 36.7% year-over-year to ¥1,799 million, and comprehensive income dropped 67.1% to ¥1,753 million.
Earnings per share for Q3 FY2025 was ¥47.08, down from ¥74.44 in the prior year.
Financial highlights
Gross profit increased to ¥25,301 million from ¥21,534 million year-over-year.
Selling, general, and administrative expenses rose to ¥21,467 million from ¥19,050 million.
Total assets as of December 31, 2024, were ¥219,145 million, with net assets at ¥105,291 million and a capital adequacy ratio of 48.0%.
Depreciation and amortization for the nine months ended December 31, 2024, totaled ¥3,676 million.
Outlook and guidance
Full-year FY2025 net sales are forecast at ¥148,000 million, up 6.9% year-over-year.
Operating income is projected at ¥10,000 million (down 13.0%), ordinary income at ¥9,500 million (down 36.0%), and net income at ¥6,000 million (down 24.9%).
Annual dividend forecast is ¥85.00 per share, up from ¥70.00 in the previous year.
Latest events from Ishihara Sangyo Kaisha
- Strong profit growth and positive outlook, driven by Organic Chemicals segment.4028
Q3 202613 Feb 2026 - Net sales grew 10.4% year-over-year, but net income fell sharply by 80.6%.4028
Q2 202520 Nov 2025 - Q1 FY2025 profit dropped over 40% year-over-year despite stable sales; outlook revised down.4028
Q1 202520 Nov 2025 - Net sales up 4.9% year-over-year, with profit and dividend growth forecast for FY2026.4028
Q4 202520 Nov 2025 - Operating profit surged 191% year-over-year, with strong sales and raised full-year guidance.4028
Q1 202620 Nov 2025 - Operating profit and net income surged, with robust outlook and higher full-year forecasts.4028
Q2 202620 Nov 2025